| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.33 | 0.04 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.05 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |